Diagnostic Testing & Technology Report

Life sciences and biotechnology company Enzo Biochem (Farmingdale, N.Y.) has paid $18 million in cash and stock to acquire privately held Biomol International (Plymouth Meeting, Pa., and Exeter, England). With annual revenues of approximately $12 million and 50 employees in its United States and United Kingdom facilities, Biomol produces specialty life science products in the areas of signal transduction, lipid research, apoptosis, neuroscience, and drug discovery, with a research focus in functional proteomics.